Capricor Therapeutics | CAPR - Debt

Stock Price
34.68
Daily Change
0.14 0.41%
Monthly
13.48%
Yearly
253.16%
Q2 Forecast
30.35

Capricor Therapeutics reported $3.38M in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Bioline Rx USD 11.38M 1.22M Sep/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cipla INR 4.38B 231.9M Mar/2025
Cytokinetics USD 1.2B 338.79M Sep/2025
Geron USD 121.92M 73K Sep/2025
Grifols EUR 9.23B 626.05M Dec/2024
Immunic USD 0 0 Jun/2024
J&J USD 47.93B 2.14B Dec/2025
Plus Therapeutics USD 3.98M 372K Dec/2023
Prothena USD 9.08M 699K Sep/2025
PTC Therapeutics USD 286.32M 306K Sep/2025
Sarepta Therapeutics USD 1.25B 103.69M Sep/2025